Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients

Saved in:
Bibliographic Details
Published inBlood cancer journal (New York) Vol. 13; no. 1; p. 50
Main Authors Alcheikh, Ahmad, Perkins, Griffith B., Pucar, Phillippa A., Cecchin, Amelia, Chai, Cheng Sheng, Tunbridge, Matthew, Akerman, Anouschka, Aggarwal, Anupriya, Milogiannakis, Vanessa, Turville, Stuart, Allen, Sharon, Hissaria, Pravin, Banovic, Tatjana, Coates, P. Toby, Ross, David M.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 10.04.2023
Springer Nature B.V
Nature Publishing Group
Subjects
631/250/1619/554
631/250/2152
692/699/1541/1990/2331
692/699/255
692/700/459/1748
82/1
Biomedical and Life Sciences
Biomedicine
Cancer Research
Correspondence
COVID-19 - prevention & control
Hematology
Humans
Immunity, Cellular
Oncology
Primary Myelofibrosis - genetics
SARS-CoV-2
Vaccination
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:2044-5385
2044-5385
DOI:10.1038/s41408-023-00824-8